Search Results - "Ebrahimitirtashi, Azadeh"

Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study

Salehi, Zahra ^{a, b}, Naghizadeh, Mohammad Mehdi ^c, Ezabadi, Sajjad Ghane ^d, Ebrahimitirtashi, Azadeh ^d, Abbasi Kasbi, Naghmeh ^d, Khodaie, Faezeh ^d, Aliyari, Shahram ^{e, f}, Ashtari, Fereshteh ^g, Baghbanian, Seyed Mohammad ^h, Nabavi, Seyed Massood ⁱ, Hosseini, Samaneh ^j, Razazian, Nazanin ^k, Shaygannejad, Vahid ^g, Majdi-Nasab, Nastaran ^l, Harirchian, Mohammad Hossein ^m, Bayati, Asghar ⁿ, Kamali, Hoda ^o, Hosseni Nejad Mir, Nahid ^p, Beladi Moghadam, Nahid ^q, Poursadeghfard, Maryam ^r, Mozhdehipanah, Hossein ^s, Jalali, Nazanin ^t, Nahayati, Mohammad Ali ^u, Faraji, Fardin ^v, Kamyari, Naser ^w, Sahraian, Mohammad Ali ^d, Maghbooli, Zhila ^d, Eskandarieh, Sharareh ^{d, ⁎}

143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry

Ezabadi, Sajjad Ghane ¹, Ebrahimitirtashi, Azadeh ¹, Salehi, Zahra ², Kasbi, Naghmeh Abbasi ¹, Khodaie, Faezeh ¹, Naghizadeh, Mohammad Mehdi ³, Nabavi, Seyed Massood ⁴, Moghadam, Nahid Beladi ⁵, Sahraian, Mohammad Ali ¹, Eskandarieh, Sharareh ¹

Parental Consanguinity and the Age at Onset in Multiple Sclerosis: A National Registry-Based Analysis of Familial Cases of Iran

Eskandarieh, Sharareh, Salehi, Zahra, Ezabadi, Sajjad Ghane, Naghizadeh, Mohammad Mehdi, Ebrahimitirtashi, Azadeh, Sahraian, Mohammad Ali, Kasbi, Naghmeh Abbasi, Khodaie, Faezeh, Aliyari, Shahram

The Rate and Pattern of Changes in MS Disease Modifying Drugs in Tehran, Iran; a Cross-Sectional Study from Tehran MS Registry

Eskandarieh, Sharareh, Salehi, Zahra, Ebrahimitirtashi, Azadeh, Abbasi, Naghmeh, Khodaie, Faezeh, Madreseh, Elham, Nabavi, Seyed Massood, Moghadam, Nahid Beladi, Sahraian, Mohammad Ali, Ezabadi, Sajjad Ghane

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.